Marc Guëll

Founder at S-Biomedic NV

Commercial Services

Consumer Non-Durables

Profile

Marc Guëll is associated with two companies, eGenesis, Inc. and S-Biomedic NV.
He is a founding scientist at eGenesis, Inc. and a scientific director at S-Biomedic NV.
eGenesis, Inc. was founded in 2015 and S-Biomedic NV was founded in 2014.

Marc Guëll active positions

Companies	Position	Start
S-Biomedic NV S-Biomedic NV Household/Personal CareConsumer Non-Durables Part of maxingvest AG, S-Biomedic NV is a Belgian company that develops skin microbiome manipulation technology which allows to transplant beneficial bacteria on the skin. The company is based in Beerse, Belgium. The company was founded in 2014 by Bernhard Päetzold, Veronika Oudova, Marc Guëll. Veronika Oudova has been the CEO since 2014. S-Biomedic was acquired by Beiersdorf AG on December 16, 2022.	Founder	2013-12-31

All active positions of Marc Guëll

Former positions of Marc Guëll

Companies	Position	End
eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	Founder	-

See the detail of Marc Guëll's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Guëll's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	Commercial Services
S-Biomedic NV S-Biomedic NV Household/Personal CareConsumer Non-Durables Part of maxingvest AG, S-Biomedic NV is a Belgian company that develops skin microbiome manipulation technology which allows to transplant beneficial bacteria on the skin. The company is based in Beerse, Belgium. The company was founded in 2014 by Bernhard Päetzold, Veronika Oudova, Marc Guëll. Veronika Oudova has been the CEO since 2014. S-Biomedic was acquired by Beiersdorf AG on December 16, 2022.	Consumer Non-Durables